Back to Browse Journals » International Journal of High Throughput Screening » Volume 2

Drug discovery in Parkinson's disease: update and developments in the use of cellular models

Authors Skibinski G, Finkbeiner S

Published Date June 2011 Volume 2011:2 Pages 15—25


Published 30 June 2011

Gaia Skibinski, Steven Finkbeiner
Gladstone Institute of Neurological Disease, San Francisco, CA, USA

Abstract: Parkinson's disease is the second most common neurodegenerative disorder and is characterized by the degeneration of dopaminergic neurons within the substantia nigra. Dopamine replacement drugs remain the most effective treatment for Parkinson's disease but only provide temporary symptomatic relief. New therapies are urgently needed, but the search for a disease-modifying treatment and a definitive understanding of the underlying mechanisms of Parkinson's disease has been limited by the lack of physiologically relevant models that recapitulate the disease phenotype. The use of immortalized cell lines as in vitro model systems for drug discovery has met with limited success, because efficacy and safety too often fail to translate successfully in human clinical trials. Drug discoverers are shifting their focus to more physiologically relevant cellular models, including primary neurons and stem cells. The recent discovery of induced pluripotent stem cell technology presents an exciting opportunity to derive human dopaminergic neurons from patients with sporadic and familial forms of Parkinson's disease. We anticipate that these human dopaminergic models will recapitulate key features of the Parkinson's disease phenotype. In parallel, high-content screening platforms, which extract information on multiple cellular features within individual neurons, provide a network-based approach that can resolve temporal and spatial relationships underlying mechanisms of neurodegeneration and drug perturbations. These emerging technologies have the potential to establish highly predictive cellular models that could bring about a desperately needed revolution in Parkinson's disease drug discovery.

Keywords: Parkinson's disease, cellular models, drug delivery

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:


Skibinski G, Finkbeiner S

International Journal of High Throughput Screening 2011, 2:27-28

Published Date: 22 September 2011

Readers of this article also read:

Comparison of patient outcomes in academic medical centers with and without value analysis programs

Murray AS, Griswold M, Sunesara I, Smith E

Journal of Healthcare Leadership 2012, 4:93-105

Published Date: 3 September 2012

Lung microbiology and exacerbations in COPD

Beasley V, Joshi PV, Singanayagam A, Molyneaux PL, Johnston SL, Mallia P

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:555-569

Published Date: 31 August 2012

Public optimism towards nanomedicine

Bottini M, Rosato N, Gloria F, Adanti S, Corradino N, Bergamaschi A, Magrini A

International Journal of Nanomedicine 2011, 6:3473-3485

Published Date: 20 December 2011

Power optimized variation aware dual-threshold SRAM cell design technique

Aminul Islam, Mohd Hasan

Nanotechnology, Science and Applications 2011, 4:25-33

Published Date: 10 February 2011

Use and potential of nanotechnology in cosmetic dermatology

Pierfrancesco Morganti

Clinical, Cosmetic and Investigational Dermatology 2010, 3:5-13

Published Date: 24 February 2010

Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic participation of inflammatory peroxynitrite

Takahiro Ueno, Hironori Tsuchiya, Maki Mizogami, Ko Takakura

Journal of Inflammation Research 2008, 1:41-48

Published Date: 13 November 2008

Editorial: Regulation of nanotechnology: Are we doing enough? ||FREE PAPER||

Thomas J Webster

International Journal of Nanomedicine 2007, 2:275-276

Published Date: 10 October 2007

Micro- and nanotechnology in cell separation || FREE PAPER ||

Milica Radisic, Rohin K Iyer, Shashi K Murthy

International Journal of Nanomedicine 2006, 1:3-14

Published Date: 25 January 2006